FDA peptides panel includes doctors with ties to industry
WASHINGTON (AP) — When U.S. health officials meet next month to reconsider a list of controversial peptide drugs,…
States look to drop prescription costs by reining in middlemen
TOPEKA, Kan. (AP) — As consumers worry about medication costs, states are trying to lower drug prices by…